New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 19, 2013
08:06 EDTNBYNovaBay plans to reinitiate clinical evaluation of Auriclosene for impetigo
NovaBay Pharmaceuticals announced that it expects to reinitiate a Phase 2b clinical trial of auriclosene for impetigo in 2014. Knowledge gained from the two previous impetigo studies is expected to lead to the use of an optimized formulation of auriclosene for this upcoming clinical trial. NovaBay will be responsible for the planning and execution of the upcoming trial.
News For NBY From The Last 14 Days
Check below for free stories on NBY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NBY

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use